BioNTech's stock surged 20.2% after partnering with Bristol Myers Squibb for cancer immunotherapy.

Several healthcare and biotech stocks are in the spotlight today, with Blueprint Medicines, Novo Nordisk, and Basel Medical Group leading growth stocks. BioNTech's stock surged 20.2% post-its partnership with Bristol Myers Squibb for cancer immunotherapy. UnitedHealth Group, Alphabet, and Tempus AI are top healthcare traders, while MarketBeat highlights biotech stocks like Lyra Therapeutics and BioNTech. The Motley Fool recommends Amgen, Vertex Pharmaceuticals, and Summit Therapeutics for their promising pipelines and growth potential.